UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041488
Receipt number R000047356
Scientific Title A comparative study of laparoscopic hepatectomy, open hepatectomy and percutaneous radiofrequency ablation for small hepatocellular carcinoma: SURF-additional study
Date of disclosure of the study information 2020/08/30
Last modified on 2023/08/24 09:35:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A comparative study of laparoscopic hepatectomy, open hepatectomy and percutaneous radiofrequency ablation for small hepatocellular carcinoma: SURF-additional study

Acronym

Laparoscopic hepatectomy vs. open hepatectomy vs. RFA for HCC: SURF-additional study

Scientific Title

A comparative study of laparoscopic hepatectomy, open hepatectomy and percutaneous radiofrequency ablation for small hepatocellular carcinoma: SURF-additional study

Scientific Title:Acronym

Laparoscopic hepatectomy vs. open hepatectomy vs. RFA for HCC: SURF-additional study

Region

Japan


Condition

Condition

A primary hepatocellular carcinoma case with tumor foci numbering less than 3, each measuring 3 cm or less, Child-Pugh score of 7 or less, ages between 20 and 79 year, and indications for either surgical resection or radiofrequency ablation for the treatment

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare the short-term results, long-term results and treatment difficulty of laparoscopic hepatectomy, open hepatectomy, and RFA using registered cases of the nationwide multicenter study (SURF trial).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

overall survival, recurrence-free survival

Key secondary outcomes

Postoperative hospital stays, complications, treatment difficulty (tumor location, tumor diameter, Child-Pugh, proximity of major blood vessel to tumor)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

79 years-old >=

Gender

Male and Female

Key inclusion criteria

1) no preceded treatment
2) tumor foci numbering less than 3 and each measuring 3 cm or less exhibiting typical findings on dynamic CT
3) no extrahepatic lesion or vascular invasion
4) Child-Pugh score of 7 or less
5) tumors which can be curatively treated with both surgery and radiofrequency ablation
6) performance status 0-2
7) bone marrow function and hepatic/renal functions are well maintained
a)White blood cell count: 2000-10000/mm3
b)Platelet count of 50000/mm3 or more
c)Hemoglobin of 8.0g/dL or more
d)Serum total bilirubin of 2.0mg/dL or less
e)Prothronbin time of 50% or more
f)Serum creatinine of 1.5mg/dL or less
g)Blood urea nitrogen of 35mg/dL or less

Key exclusion criteria

1) Double cancer or history of other malignancy within 5 years after diagnosis
2) History of myocardial infarction or unstable angina within 6 months prior to registration
3) Patient with interstitial pneumonia, pneumofibrosis, or severe lung emphysema
4) Patient who cannot undergo enhanced CT scan due to some reason such as allergy for iodized contrast media or renal dysfunction
5) Patient with psychiatric disorder or symptom
6) Pregnant patient or patient with possibility to be pregnant

Target sample size

1090


Research contact person

Name of lead principal investigator

1st name Masafumi
Middle name
Last name Inomata

Organization

Oita University Faculty of Medicine

Division name

Department of Gastroenterological and Pediatric Surgery

Zip code

879-5593

Address

1-1 Idaigaoka, Hasama-machi, Yufu

TEL

097-586-5843

Email

inomata@oita-u.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Masuda

Organization

Oita University Faculty of Medicine

Division name

Department of Gastroenterological and Pediatric Surgery

Zip code

879-5593

Address

1-1 Idaigaoka, Hasama-machi, Yufu

TEL

097-586-5843

Homepage URL

http://www.surftrial.jp

Email

tmasuda@oita-u.ac.jp


Sponsor or person

Institute

Surgery vs. RFA (SURF) trail group

Institute

Department

Personal name



Funding Source

Organization

Oita Cancer Research Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Oita University Faculty of Medicine, Department of Gastroenterological and Pediatric Surgery

Address

1-1 Idaigaoka, Hasama-machi, Yufu

Tel

097-586-5843

Email

tmasuda@oita-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 06 Month 22 Day

Date of IRB

2020 Year 06 Month 22 Day

Anticipated trial start date

2020 Year 06 Month 22 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2020 Year 08 Month 20 Day

Last modified on

2023 Year 08 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047356


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name